Moderna Inc (MRNA), a much discussed stock over the previous years, is having a +8% day, a very encouraging since following the rejection on the 1D MA50 (blue trend-line) three days ago. What's more interesting is that we have seen almost the same pattern in the stock's all time lows in 2019. As you see, the price since September has been on Lower Lows while the...
We all know this stock saw a large rise due to world conditions over the last few years, but since that has mostly come to and end, it's time to let MRNA rest for a while. This looks like a massive Head & Shoulders if I've ever seen one, this could bring price as far down as $30, but more than likely will find some major support at below $90 in the medium term....
EXPLOSIVE potential ! What does mRNA do ? mRNA produces instructions to make proteins that may treat or prevent disease. mRNA medicines aren’t small molecules, like traditional pharmaceuticals. And they aren’t traditional biologics (recombinant proteins and monoclonal antibodies) – which were the genesis of the biotech industry. Instead, mRNA medicines are...
Head and shoulders on Moderna stock. Biden over the weekend stated the pandemic is over based off headline news.. Just a matter of time until the stock is worth about 40-70$.. been waiting on this. This company was worth decimals before the pandemic lol.
$MRNA Joe Biden says the COVID-19 pandemic is over. After breakdown 140 zone , now we ca go to 115 lvl june lows, #doublebottom #markets #stocks $SPX
Suggesting a recovery at 104.28 for Moderna A bottom is attempting to form This recovery point is along a stronger yet lower trend line
Moderna Short Term We look to Sell at 183.71 (stop at 203.39) Preferred trade is to sell into rallies. Previous resistance located at 190.00. Trading within a Bearish Channel formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our profit targets will be...
All description on the chart. Please, don't forget to like and follow. Thank you.
Moderna Short Term We look to Sell at 146.42 (stop at 154.23) Preferred trade is to sell into rallies. Price action has posted a bearish Shooting Star and is negative for short-term sentiment. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look...
The statistics are between $184 - $219(1 Year) Its Financial Health is very strong. Why not wait till Moderna makes greater progress and finds It Resistance Again at $450 Moderna has many projects running. So if we see progress in some of the projects in the next Years, we will see a great price rise. I believe it won't be difficult to reach its older...
Nice breakout from that bullish pennant flag🔥 Monkeypox might be the next Pandemic (according to WHO) and $SIGA might be the next $MRNA (5000% up since the beginning of Covid)🚀📈
Moderna Short Term We look to Sell at 133.52 (stop at 141.88) Preferred trade is to sell into rallies. Prices expected to stall near trend line resistance. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our...
Moderna Short Term - We look to Sell at 149.49 (stop at 160.31) Preferred trade is to sell into rallies. Closed below the 20-day EMA. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 123.84 and 103.50 Resistance: 150.00...
New York-based pharmaceutical firm SIGA Technologies (NASDAQ:SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox. Smallpox jabs vs monkeypox On May 19, the World Health...
The Moderna share price has fallen from its pandemic peak amid uncertain demand for its lifesaving mRNA vaccine. But will it ever recover? Moderna (NASDAQ:MRNA) shares traded for more than $450 last summer. But today the stock is trading at $136 – less than a third of its pandemic peak. The vaccine-maker stock gained massively during the pandemic. Its mRNA...
Bullish Flag on MRNA, Target Price 185 which is a swing high. Earning report was good, people use and need drugs and will continue to use and need.
You can see many supporting facts for my prediction on the chart... NASDAQ:MRNA
Pfizer and Moderna are strangely growing up in an age where covid disappears In the past few years it has happened before a new covid wave Is a new variant planned for October 2022 ?? I'm kidding :) Perhaps..